At the onset of MS, the levels of OPG in the cerebrospinal fluid (CSF) are decreased, while serum levels of OPG are comparable in RRMS patients, subjects with the initial stage of MS, and healthy controls [53]. This evidence concerns the gene TNFRSF11B and myeloid sarcoma.